Overview

Hormone Evaluation in Artificial Reproductive Technology

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The aim is to be able to predict the hormonal response according to gonadotropin receptor genotype and hormone type used for treatment of women undergoing in vitro fertilization or egg donation. Outcome will be measured as pregnancy success, live born babies and unwanted side effects.
Phase:
Phase 4
Details
Lead Sponsor:
Lund University
Collaborator:
Ferring Pharmaceuticals
Treatments:
Follicle Stimulating Hormone
Menotropins